#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	16460	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2133	768.7	0	.	n	.	0	A69G	SNP	69	69	A	369	369	G	891	G,A	410,386	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	16460	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2133	768.7	1	SNP	n	C1184T	0	.	.	1184	1184	C	1484	1484	C	1003	C	903	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	16460	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2133	768.7	0	HET	.	.	.	G298A	.	298	298	G	598	598	G	943	G,A	635,211	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	29584	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3501	841.8	0	.	n	.	0	T695C	SNP	695	695	T	1059	1059	C	936	C	841	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	29584	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3501	841.8	0	.	n	.	0	G1337A	SNP	1337	1337	G	1701	1701	A	1054	A,G	951,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	29584	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3501	841.8	0	.	n	.	0	T1971C	SNP	1971	1971	T	2335	2335	C	987	C	894	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	29584	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3501	841.8	1	SNP	n	A2045G	0	.	.	2045	2045	A	2409	2409	A	958	A	889	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	29584	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3501	841.8	1	SNP	n	C2597T	0	.	.	2597	2597	C	2961	2961	C	892	C,T,A	816,1,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	27	2296	folP	855	855	100.0	folP.l15.c17.ctg.1	1483	154.0	1	SNP	p	R229S	1	.	.	685	687	AGC	939	941	AGC	258;254;257	A;G;C	235;231;233	folP.WHO_Y_01480c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5994	gyrA	2751	2751	99.85	gyrA.l6.c17.ctg.1	3399	176.0	1	SNP	p	S91F	1	.	.	271	273	TTC	607	609	TTC	185;185;184	T;T;C	171;171;166	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5994	gyrA	2751	2751	99.85	gyrA.l6.c17.ctg.1	3399	176.0	1	SNP	p	G95N	0	.	.	283	285	GGC	619	621	GGC	184;182;181	G;G;C	167;167;165	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5994	gyrA	2751	2751	99.85	gyrA.l6.c17.ctg.1	3399	176.0	1	SNP	p	D95G	1	.	.	283	285	GGC	619	621	GGC	184;182;181	G;G;C	167;167;165	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	27	1814	mtrR	633	633	100.0	mtrR.l15.c17.ctg.1	1279	141.5	1	SNP	p	G45D	0	.	.	133	135	GGC	480	482	GGC	274;275;277	G;G;C	239;242;242	mtrR.WHO_Y_01506:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	892	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c30.ctg.1	1088	81.9	0	.	n	.	0	A197.	DEL	197	197	A	621	621	A	211	A	191	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5726	parC	2304	2304	100.0	parC.l6.c4.ctg.1	2857	199.6	1	SNP	p	D86N	0	.	.	256	258	GAC	548	550	GAC	260;263;268	G;A;C	233;227;233	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5726	parC	2304	2304	100.0	parC.l6.c4.ctg.1	2857	199.6	1	SNP	p	S87R	1	.	.	259	261	CGT	551	553	CGT	263;263;263	C;G;T	234;231;229	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5726	parC	2304	2304	100.0	parC.l6.c4.ctg.1	2857	199.6	1	SNP	p	R87I	0	.	.	259	261	CGT	551	553	CGT	263;263;263	C;G;T	234;231;229	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5726	parC	2304	2304	100.0	parC.l6.c4.ctg.1	2857	199.6	1	SNP	p	R87W	0	.	.	259	261	CGT	551	553	CGT	263;263;263	C;G;T	234;231;229	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5726	parC	2304	2304	100.0	parC.l6.c4.ctg.1	2857	199.6	1	SNP	p	S88P	0	.	.	262	264	TCC	554	556	TCC	264;262;263	T;C;C	232;228;229	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4850	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2580	187.2	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1519	1521	GGC	234;230;229	G;G;C	216;213;208	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.5.002	penA.5.002	1	1	27	4494	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2417	185.1	1	SNP	p	A311V	0	.	.	931	933	GCA	1286	1288	GCA	230;228;229	G;C;A	204;199;207	penA.5.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4494	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2417	185.1	1	SNP	p	I312M	0	.	.	934	936	ATC	1289	1291	ATC	232;234;235	A;T;C	209;210;214	penA.5.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4494	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2417	185.1	1	SNP	p	V316P	0	.	.	946	948	GTG	1301	1303	GTG	230;231;234	G;T;G,T	210;211;212,1	penA.5.002:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4494	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2417	185.1	1	SNP	p	V316T	0	.	.	946	948	GTG	1301	1303	GTG	230;231;234	G;T;G,T	210;211;212,1	penA.5.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4494	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2417	185.1	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1805	1807	ACC	244;243;243	A;C;C	208;215;215	penA.5.002:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4494	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2417	185.1	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1859	1861	GCG	228;223;220	G;C;G,T	193;174;176,1	penA.5.002:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4494	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2417	185.1	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1859	1861	GCG	228;223;220	G;C;G,T	193;174;176,1	penA.5.002:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4494	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2417	185.1	1	SNP	p	G543S	1	.	.	1627	1629	AGC	1982	1984	AGC	190;187;187	A;G;C	174;170;173	penA.5.002:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4494	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2417	185.1	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1991	1993	GGC	191;189;190	G;G;C	175;173;173	penA.5.002:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4494	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2417	185.1	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2009	2011	CCG	179;178;174	C,G;C;G	121,8;123;119	penA.5.002:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	6274	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3098	201.8	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1634	1636	CCG	234;233;233	C;C,T,A;G	201;203,1,1;201	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2380	porA	1146	1146	99.91	porA.l15.c17.ctg.1	1775	133.5	0	.	p	.	0	M83fs	FSHIFT	247	247	A	468	468	C	167	C	150	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	320	porB1a	984	271	91.14	porB1a.l15.c30.ctg.2	381	31.5	0	.	p	.	0	V258L	NONSYN	772	774	GTA	90	92	TTA	59;62;62	T;T;A	51;53;53	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	320	porB1a	984	271	91.14	porB1a.l15.c30.ctg.2	381	31.5	0	.	p	.	0	Y273H	NONSYN	817	819	TAT	135	137	CAT	61;62;61	C;A;T	54;53;54	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	320	porB1a	984	271	91.14	porB1a.l15.c30.ctg.2	381	31.5	0	.	p	.	0	D274S	NONSYN	820	822	GAT	138	140	AGT	62;61;61	A;G;T	54;53;54	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	320	porB1a	984	271	91.14	porB1a.l15.c30.ctg.2	381	31.5	0	.	p	.	0	N277Y	NONSYN	829	831	AAC	147	149	TAC	62;62;62	T;A;C	55;55;55	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	320	porB1a	984	271	91.14	porB1a.l15.c30.ctg.2	381	31.5	0	.	p	.	0	R307A	NONSYN	919	921	AGA	237	239	GCA	13;12;12	G;C;A	12;11;11	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	320	porB1a	984	271	91.14	porB1a.l15.c30.ctg.2	381	31.5	0	.	p	.	0	T311A	NONSYN	931	933	ACA	249	251	GCA	10;10;10	G;C;A	9;9;10	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	320	porB1a	984	271	91.14	porB1a.l15.c30.ctg.2	381	31.5	0	.	p	.	0	E312D	NONSYN	934	936	GAA	252	254	GAC	10;9;9	G;A;C,A	9;9;8,1	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	320	porB1a	984	271	91.14	porB1a.l15.c30.ctg.2	381	31.5	0	.	p	.	0	F314I	NONSYN	940	942	TTC	258	260	ATC	9;9;10	A;T;C	7;7;8	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	320	porB1a	984	271	91.14	porB1a.l15.c30.ctg.2	381	31.5	0	.	p	.	0	A316S	NONSYN	946	948	GCG	264	266	TCG	10;10;10	T;C;G	8;10;8	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	320	porB1a	984	271	91.14	porB1a.l15.c30.ctg.2	381	31.5	0	.	p	.	0	T317P	NONSYN	949	951	ACT	267	269	CCT	11;11;11	C,A;C;T	0,8;8;8	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	320	porB1a	984	271	91.14	porB1a.l15.c30.ctg.2	381	31.5	0	.	p	.	0	V318A	NONSYN	952	954	GTC	270	272	GCC	11;11;11	G;C;C	8;10;8	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	320	porB1a	984	271	91.14	porB1a.l15.c30.ctg.2	381	31.5	0	.	p	.	0	G319S	NONSYN	955	957	GGC	273	275	AGC	11;11;11	A;G;C	8;8;10	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	320	porB1a	984	271	91.14	porB1a.l15.c30.ctg.2	381	31.5	0	.	p	.	0	G320A	NONSYN	958	960	GGT	276	278	GCC	11;12;12	G;C;C	6;11;9	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	320	porB1a	984	271	91.14	porB1a.l15.c30.ctg.2	381	31.5	0	.	p	.	0	G322V	NONSYN	964	966	GGT	282	284	GTT	13;13;13	G;T;T	10;13;12	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2956	porB1b	1047	1047	99.24	porB1b.l6.c4.ctg.1	1518	193.1	0	.	p	.	0	N38E	NONSYN	112	114	AAT	346	348	GAA	264;262;262	G;A,T;A	240;236,1;233	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2956	porB1b	1047	1047	99.24	porB1b.l6.c4.ctg.1	1518	193.1	0	.	p	.	0	N134D	NONSYN	400	402	AAT	634	636	GAT	227;227;230	G,A;A;T	204,1;209;213	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2956	porB1b	1047	1047	99.24	porB1b.l6.c4.ctg.1	1518	193.1	0	.	p	.	0	P175S	NONSYN	523	525	CCA	757	759	TCA	237;237;237	T;C;A	214;215;214	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2956	porB1b	1047	1047	99.24	porB1b.l6.c4.ctg.1	1518	193.1	0	.	p	.	0	A218V	NONSYN	652	654	GCC	886	888	GTC	251;250;254	G;T,C;C	231;227,1;233	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2956	porB1b	1047	1047	99.24	porB1b.l6.c4.ctg.1	1518	193.1	0	.	p	.	0	F222S	NONSYN	664	666	TTT	898	900	TCT	253;250;251	T;C;T	236;237;236	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2956	porB1b	1047	1047	99.24	porB1b.l6.c4.ctg.1	1518	193.1	0	.	p	.	0	E328A	NONSYN	982	984	GAA	1216	1218	GCA	223;222;225	G;C;A,T	205;203;205,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2956	porB1b	1047	1047	99.24	porB1b.l6.c4.ctg.1	1518	193.1	1	SNP	p	G120K	1	.	.	358	360	AAG	592	594	AAG	216;216;214	A,G;A,G;G,C	201,1;199,1;197,1	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2956	porB1b	1047	1047	99.24	porB1b.l6.c4.ctg.1	1518	193.1	1	SNP	p	A121D	1	.	.	361	363	GAC	595	597	GAC	213;212;215	G;A,C;C	196;193,1;198	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2956	porB1b	1047	1047	99.24	porB1b.l6.c4.ctg.1	1518	193.1	1	SNP	p	D121N	0	.	.	361	363	GAC	595	597	GAC	213;212;215	G;A,C;C	196;193,1;198	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	11302	rpoB	4179	4179	99.98	rpoB.l15.c30.ctg.1	4779	235.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1196	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1009	118.1	1	SNP	p	V57M	1	.	.	169	171	ATG	515	517	ATG	275;272;274	A;T;G	254;251;251	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
